ARYX
Price:
$0.0005
Market Cap:
$16.73K
ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets. The company uses its RetroMetabolic Drug Design technology to design structurally unique molecules that retain the efficacy of original drugs. Its products in clinical development portfolio include Tecarfarin (ATI-5923), an oral anticoagulant, which is in Phase III clinical development for the treatment of patients who are at risk for the formation of dangerous blood clots; and Budiodarone (ATI-2042), an oral antiarrhythmic agent that is in Phase IIb clinical development for the treatment of atrial fibrillation, a form of irregular heartbeat. The company's other clinical development products ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2007-11-07
Stock Exchange
PNK
Ticker
ARYX
According to ARYx Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -99.44% compared to the average of -1.78 of the last 4 quarters.
The mean historical PE Ratio of ARYx Therapeutics, Inc. over the last ten years is -0.96. The current -0.01 PE Ratio has changed 3.81% with respect to the historical average. Over the past ten years (40 quarters), ARYX's PE Ratio was at its highest in in the September 2008 quarter at 8.36. The PE Ratio was at its lowest in in the December 2007 quarter at -4.22.
Average
-0.96
Median
-0.49
Minimum
-2.66
Maximum
-0.26
Discovering the peaks and valleys of ARYx Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 211.82%
Maximum Annual PE Ratio = -0.26
Minimum Annual Increase = -31.34%
Minimum Annual PE Ratio = -2.66
Year | PE Ratio | Change |
---|---|---|
2009 | -2.66 | 50.74% |
2008 | -1.76 | 87.24% |
2007 | -0.94 | 211.82% |
2006 | -0.30 | 14.47% |
2005 | -0.26 | -21.01% |
2004 | -0.33 | -31.34% |
The current PE Ratio of ARYx Therapeutics, Inc. (ARYX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.79
5-year avg
-1.18
10-year avg
-0.96
ARYx Therapeutics, Inc.’s PE Ratio is less than Medicure Inc. (0), greater than Mountain High Acquisitions Corp. (-4.57), less than Creative Edge Nutrition, Inc. (-0.00), greater than OWC Pharmaceutical Research Corp. (-0.02), less than Ascend Wellness Holdings, Inc. (0), greater than Incannex Healthcare Limited (-0.93), greater than Silver Spike Investment Corp. (-2.55), less than Phibro Animal Health Corporation (0), less than Supernus Pharmaceuticals, Inc. (50.36), less than null (32.88),
Company | PE Ratio | Market cap |
---|---|---|
0 | $6.78M | |
-4.57 | $220.00 | |
-0.00 | $46.30K | |
-0.02 | $49.75K | |
0 | $81.46M | |
-0.93 | $30.87M | |
-2.55 | $66.72M | |
0 | $876.50M | |
50.36 | $1.97B | |
32.88 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ARYx Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ARYx Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is ARYx Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for ARYx Therapeutics, Inc. (ARYX)?
What is the highest PE Ratio for ARYx Therapeutics, Inc. (ARYX)?
What is the 3-year average PE Ratio for ARYx Therapeutics, Inc. (ARYX)?
What is the 5-year average PE Ratio for ARYx Therapeutics, Inc. (ARYX)?
How does the current PE Ratio for ARYx Therapeutics, Inc. (ARYX) compare to its historical average?